New pro-inflammatory cytokine IL-40 is produced by activated neutrophils and plays a role in the early stages of seropositive rheumatoid arthritis
Language English Country Great Britain, England Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
37208028
PubMed Central
PMC10201233
DOI
10.1136/rmdopen-2022-002894
PII: rmdopen-2022-002894
Knihovny.cz E-resources
- Keywords
- Autoantibodies, Cytokines, Early Rheumatoid Arthritis,
- MeSH
- Autoantibodies MeSH
- Cytokines MeSH
- Interleukin-8 MeSH
- Interleukins MeSH
- Humans MeSH
- Neutrophils * MeSH
- Arthritis, Rheumatoid * MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Autoantibodies MeSH
- Cytokines MeSH
- Interleukin-8 MeSH
- Interleukins MeSH
OBJECTIVE: Interleukin (IL)-40 is a new cytokine related to immune system function and malignancies. Recently, an association of IL-40 with rheumatoid arthritis (RA) and externalisation of neutrophil extracellular traps (NETosis) was found. As neutrophils are implicated in RA development, we investigated IL-40 in early stages of RA (ERA). METHODS: IL-40 was determined in serum of treatment naïve patients with ERA at baseline (n=60) and 3 months after initiation of conventional therapy and in healthy controls (HC; n=60). Levels of IL-40, cytokines and NETosis markers were measured by ELISA. NETosis was visualised by immunofluorescence. In vitro experiments were performed on peripheral blood neutrophils from ERA patients (n=14). Cell-free DNA was analysed in serum and supernatants. RESULTS: Serum IL-40 was elevated in ERA compared with HC (p<0.0001) and normalised after 3 months of therapy (p<0.0001). Baseline serum IL-40 correlated with rheumatoid factor (IgM) (p<0.01), anti-cyclic citrullinated peptide (p<0.01) autoantibodies and NETosis markers (proteinase 3; neutrophil elastase (NE); myeloperoxidase) (p<0.0001). Levels of NE significantly decreased after therapy (p<0.01) and correlated with the decrease of serum IL-40 (p<0.05). In vitro, neutrophils enhanced IL-40 secretion following NETosis induction (p<0.001) or after exposure to IL-1β, IL-8 (p<0.05), tumour necrosis factor or lipopolysaccharide (p<0.01). Recombinant IL-40 up-regulated IL-1β, IL-6 and IL-8 (p<0.05 for all) in vitro. CONCLUSION: We showed that IL-40 is significantly up-regulated in seropositive ERA and decreases after conventional therapy. Moreover, neutrophils are an important source of IL-40 in RA, and its release is potentiated by cytokines and NETosis. Thus, IL-40 may play a role in ERA.
1st Faculty of Medicine Charles University Prague Czech Republic
2nd Faculty of Medicine Charles University Prague Czech Republic
Department of Paediatric Haematology and Oncology Motol University Hospital Prague Czech Republic
Department of Rheumatology Institute of Rheumatology Prague Czech Republic
See more in PubMed
Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet 2001;358:903–11. 10.1016/S0140-6736(01)06075-5 PubMed DOI
Burmester GR, Pope JE. Novel treatment strategies in rheumatoid arthritis. The Lancet 2017;389:2338–48. 10.1016/S0140-6736(17)31491-5 PubMed DOI
Smolen JS, Landewé RBM, Bijlsma JWJ, et al. . EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying Antirheumatic drugs: 2019 Update. Ann Rheum Dis 2020;79:685–99. 10.1136/annrheumdis-2019-216655 PubMed DOI
Finckh A, Liang MH, van Herckenrode CM, et al. . Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta-analysis. Arthritis Rheum 2006;55:864–72. 10.1002/art.22353 PubMed DOI
Raza K, Falciani F, Curnow SJ, et al. . Early rheumatoid arthritis is characterized by a distinct and transient Synovial fluid cytokine profile of T cell and Stromal cell origin. Arthritis Res Ther 2005;7:R784–95. 10.1186/ar1733 PubMed DOI PMC
Ridgley LA, Anderson AE, Pratt AG. What are the dominant Cytokines in early rheumatoid arthritis Curr Opin Rheumatol 2018;30:207–14. 10.1097/BOR.0000000000000470 PubMed DOI PMC
Catalan-Dibene J, Vazquez MI, Luu VP, et al. . Identification of IL-40, a novel B cell-associated cytokine. J Immunol 2017;199:3326–35. 10.4049/jimmunol.1700534 PubMed DOI PMC
Catalan-Dibene J, McIntyre LL, Zlotnik A. Interleukin 30 to interleukin 40. J Interferon Cytokine Res 2018;38:423–39. 10.1089/jir.2018.0089 PubMed DOI PMC
Rizzo C, Lo Pizzo M, Mohammadnezhad L, et al. . Pos0177 potential involvement of IL-40 and IL-40-producing cells in primary Sjogren’s syndrome (Pss) and Pss-associated lymphoma. Ann Rheum Dis 2021;80(Suppl 1):301. 10.1136/annrheumdis-2021-eular.3792 DOI
Rizzo C, La Barbera L, Lo Pizzo M, et al. . Pos0101 potential involvement of Il-40 and Il-40 producing cells in systemic lupus erythematosus and lupus associated nephritis. Ann Rheum Dis 2022;81(Suppl 1):273. 10.1136/annrheumdis-2022-eular.4803 DOI
Navrátilová A, Andrés Cerezo L, Hulejová H, et al. . IL-40: A new B cell-associated cytokine up-regulated in rheumatoid arthritis decreases following the Rituximab therapy and correlates with disease activity, Autoantibodies, and Netosis. Front Immunol 2021;12:745523. 10.3389/fimmu.2021.745523 PubMed DOI PMC
AG Al Ghuraibawi Z, Sharquie IK, Gorial FI. Diagnostic potential of Interleukin-40 (IL-40) in rheumatoid arthritis patients. The Egyptian Rheumatologist 2022;44:377–80. 10.1016/j.ejr.2022.07.007 DOI
Lee J, Hever A, Willhite D, et al. . Effects of RNA degradation on gene expression analysis of human postmortem tissues. FASEB J 2005;19:1356–8. 10.1096/fj.04-3552fje PubMed DOI
Liu Z, Meng J, Li X, et al. . Identification of Hub genes and key pathways associated with two subtypes of diffuse large B-cell lymphoma based on gene expression profiling via integrated Bioinformatics. BioMed Research International 2018;2018:1–14. 10.1155/2018/3574534 PubMed DOI PMC
Zhou H, Xu-Monette ZY, Xiao L, et al. . Prognostic factors, therapeutic approaches, and distinct Immunobiologic features in patients with primary Mediastinal large B-cell lymphoma on long-term follow-up. Blood Cancer J 2020;10:49. 10.1038/s41408-020-0312-7 PubMed DOI PMC
Zingaretti C, Arigò M, Cardaci A, et al. . Identification of new Autoantigens by protein array indicates a role for Il4 neutralization in autoimmune hepatitis. Mol Cell Proteomics 2012;11:1885–97. 10.1074/mcp.M112.018713 PubMed DOI PMC
Gao X, Chan PKS, Lui GCY, et al. . Interleukin-38 ameliorates Poly(I:C) induced lung inflammation: Therapeutic implications in respiratory viral infections. Cell Death Dis 2021;12:53. 10.1038/s41419-020-03283-2 PubMed DOI PMC
Aletaha D, Neogi T, Silman AJ, et al. . Rheumatoid arthritis classification criteria: An American college of rheumatology/European League against rheumatism collaborative initiative. Arthritis & Rheumatism 2010;62:2569–81. 10.1002/art.27584 PubMed DOI
Blanter M, Cambier S, De Bondt M, et al. . Method matters: Effect of purification technology on neutrophil phenotype and function. Front Immunol 2022;13:820058. 10.3389/fimmu.2022.820058 PubMed DOI PMC
Navrátilová A, Bečvář V, Baloun J, et al. . S100A11 (Calgizzarin) is released via Netosis in rheumatoid arthritis (RA) and stimulates IL-6 and TNF secretion by neutrophils. Sci Rep 2021;11:6063. 10.1038/s41598-021-85561-3 PubMed DOI PMC
Pieterse E, Rother N, Yanginlar C, et al. . Neutrophils discriminate between Lipopolysaccharides of different bacterial sources and selectively release neutrophil extracellular traps. Front Immunol 2016;7:484. 10.3389/fimmu.2016.00484 PubMed DOI PMC
McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007;7:429–42. 10.1038/nri2094 PubMed DOI
Fresneda Alarcon M, McLaren Z, Wright HL. Neutrophils in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus: Same foe different M.O. Front Immunol 2021;12:649693. 10.3389/fimmu.2021.649693 PubMed DOI PMC
Berthelot J-M, Le Goff B, Neel A, et al. . Netosis: At the crossroads of rheumatoid arthritis, lupus, and vasculitis. Joint Bone Spine 2017;84:255–62.:S1297-319X(16)30106-3. 10.1016/j.jbspin.2016.05.013 PubMed DOI
Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, et al. . Nets are a source of Citrullinated Autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med 2013;5:178ra40. 10.1126/scitranslmed.3005580 PubMed DOI PMC
Laurindo IM, Mello SB, Cossermelli W. Influence of low doses of methotrexate on superoxide anion production by Polymorphonuclear leukocytes from patients with rheumatoid arthritis. J Rheumatol 1995;22:633–8. PubMed
Long F, Wang Y-X, Liu L, et al. . Rapid Nongenomic inhibitory effects of glucocorticoids on Phagocytosis and superoxide anion production by Macrophages. Steroids 2005;70:55–61. 10.1016/j.steroids.2004.10.004 PubMed DOI
Zhang C, Wei X, Omenn GS, et al. . Structure and protein interaction-based Gene Ontology Annotations reveal likely functions of Uncharacterized proteins on human Chromosome 17. J Proteome Res 2018;17:4186–96. 10.1021/acs.jproteome.8b00453 PubMed DOI PMC
Cascão R, Moura RA, Perpétuo I, et al. . Identification of a cytokine network sustaining neutrophil and Th17 activation in untreated early rheumatoid arthritis. Arthritis Res Ther 2010;12. 10.1186/ar3168 PubMed DOI PMC